Журнал "Почки" том 9, №3

Êë³í³÷íå ñïîñòåðåæåííÿ / Clinical Observation
8. Palladini G., Russo P., Nuvolone M., Lavatelli F., Perfetti V.,
Obici L., et al. Treatment with oral melphalan plus dexamethasone
produces long-term remission sin AL amyloidosis. Blood. 2007.
№ 110(2). P. 787-8.
9. Koyama J., Ray Sequin P.A., Falk R.H. Longitudinal myocardial
function assessed by tissue velocity, strain, and strain rate tissue
Doppler echocardiography in patients with AL (primary) cardiac amyloidosis.
Circulation. 2003. 107(19). P. 2446-52.
10. Palladini G., Russo P., Bosoni T., Verga L., Sarais G., Lavatelli
F., et al. Identification of amyloidogenic light chainsrequires
the combination of serum-free light chainassay with immunofixation
of serum andurine. Clin. Chem. 2009. 55(3). Р. 499-504.
11. Gertz M.A. The classification and typing of amyloid deposits.
Clin. Pathol. 2004. 121(6). Р. 787-9.
12. Захарова Е.В., Хрыкина А.В., Проскурнева Е.П., Варшавский
В.А. Случай первичного амилоидоза: трудности диагностики
и лечения. Нефрология и диализ. 2002. № 1(4). С. 54-61. http://
journal.nephro.ru/index.php?r=journal/articleView&articleId=1473
13. Kar Wah Fuah,Christopher Thiam Seong Lim. Renal-limited
AL amyloidosis — a diagnostic and management dilemma. BMC Nephrology.
2018. № 307(18). https://bmcnephrol.biomedcentral.com/
articles/10.1186/s12882-018-1118-8
14. Смирнова А.Г., Кисина А., Смирнов А.В., Цандер А., Афанасьев
Б.В. Современные методы лечения AL-амилоидоза: обзор
литературы и собственные данные. Клиническая онкогематология.
2013. № 3(6). С. 303-311.
15. BMJ Best Practice: Amyloidosis. BMJ Publishing Group.
2016 http://bestpractice.bmj.com/bestpractice/monograph/444.html.
16. Национальные клинические рекомендации по диагностике
и лечению АА- и AL-амилоидоза. Научное общество нефрологов
России. 2016. http://nonr.ru/?page_id=3178.
17. Weidemann F., Strotmann J.M. Use of tissue Doppler imaging
to identify and manage systemic diseases. Clin. Res. Cardiol. 2008.
97(2). P. 65-73.
18. Mahmood S., Venner C.P, Sachchithanantham S., Lane T.,
Rannigan L., Foard D., et al. Lenalidomide and dexamethasone for
systemic AL amyloidosis following priortreatment with thalidomide or
bortezomib regimens. Br. J. Haematol. 2014. 166(6). P. 842-8.
19. Jaccard A., Moreau P., Leblond V., Leleu X., Benboubker L.,
Hermine O., et al. High dose melphalan versus melphalan plus dexamethasone
for AL amyloidosis. N. Engl. J. Med. 2007. 357(11).
P. 1083-93.
20. Gertz M.A. Immunoglobulin light chain amyloidosis: update
on diagnosis, prognosis, and treatment. Am. J. Hematol. 2014. 89(12).
P. 1132-40.
21. Moreau P., Jaccard A., Benboubker L., Royer B., Leleu X.,
Bridoux F., et al. Lenalidomidein combination with melphalan and
dexamethasone in patients with newly diagnosed AL amyloidosis: a
multicenterphase 1/2 dose-escalation study. Blood. 2010. № 116(23).
P. 4777-82.
22. Петровский Б.В. Большая медицинская энциклопедия.
Москва: Советская энциклопедия, 1974. Т. 1. C. 576.
Отримано/Received 23.05.2020
Рецензовано/Revised 02.06.2020
Прийнято до друку/Accepted 13.06.2020
Information about authors
Rodionova V.V., MD, Professor at the Department of occupational diseases and clinical imunology, State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”, Dnipro,
Ukraine; ORCID iD: https://orcid.org/0000-0002-0221-5625
Turenko O.A., Communal non-profit institution “City Clinical Hospital 4” of the Dnipropetrovsk Regional Council, Dnipro, Ukraine; ORCID iD: https://orcid.org/0000-0002-8830-6674
Kuzhevsky I.V., Communal non-profit institution “City Clinical Hospital 4” of the Dnipropetrovsk Regional Council, Dnipro, Ukraine; ORCID iD: https://orcid.org/0000-0002-8845-7245
Tsyhankov K.V., Communal non-profit institution “City Clinical Hospital 4” of the Dnipropetrovsk Regional Council, Dnipro, Ukraine; ORCID iD: https://orcid.org/0000-0002-1536-4021
Denisenko O.O., Communal non-profit institution “City Clinical Hospital 4” of the Dnipropetrovsk Regional Council, Dnipro, Ukraine; ORCID iD: https://orcid.org/0000-0002-6541-0858
Razinina Yu.O., Communal non-profit institution “City Clinical Hospital 4” of the Dnipropetrovsk Regional Council, Dnipro, Ukraine; ORCID iD: https://orcid.org/0000-0001-6659-6407
Boiko O.O., State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”, Dnipro, Ukraine; ORCID iD: https://orcid.org/0000-0003-0506-0486
Ðîäèîíîâà Â.Â. 1 , Òóðåíêî Î.À. 2 , Êóæåâñêèé È.Â. 2 , Öûãàíêîâ Ê.Â. 2 , Äåíèñåíêî Î.Î. 2 , Ðàçèíèíà Þ.Î. 2 , Áîéêî Î.À. 1
1
Ãîñóäàðñòâåííîå ó÷ðåæäåíèå «Äíåïðîïåòðîâñêàÿ ìåäèöèíñêàÿ àêàäåìèÿ Ìèíèñòåðñòâà çäðàâîîõðàíåíèÿ Óêðàèíû»,
ã. Äíåïð, Óêðàèíà
2
Êîììóíàëüíîå íåêîììåð÷åñêîå ó÷ðåæäåíèå «Ãîðîäñêàÿ êëèíè÷åñêàÿ áîëüíèöà ¹ 4» Äíåïðîâñêîãî ãîðîäñêîãî
ñîâåòà, ã. Äíåïð, Óêðàèíà
Àìèëîèäîç êàê êëèíè÷åñêàÿ ïðîáëåìà (ñëîæíûé ñëó÷àé óñòàíîâëåíèÿ äèàãíîçà àìèëîèäîçà ïî÷åê)
Резюме. Амилоидоз является одним из самых сложных заболеваний
в терапевтической практике и может приводить к необратимым
поражениям почек с развитием хронической почечной
недостаточности. Поэтому вопросы своевременной
диагностики и раннего лечения этого заболевания являются
очень актуальными. В статье приведен клинический случай
амилоидоза почек.
Ключевые слова: амилоидоз; клинический случай; почки
V.V. Rodionova 1 , O.A. Turenko 2 ,. I.V. Kuzhevsky 2 , K.V. Tsyhankov 2 , O.O. Denisenko 2 , Yu.O. Razinina 2 , O.O. Boiko 1
1
State Institution «Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine», Dnipro, Ukraine
2
Communal Non-Profit Institution “City Clinical Hospital 4” of the Dnipro City Council, Dnipro, Ukraine
Amyloidosis as a clinical problem (a difficult case of establishing a diagnosis of renal amyloidosis)
Abstract. Amyloidosis is one of the most complex diseases in
therapeutic practice and can lead to irreversible kidney damage
with the development of chronic renal failure. Therefore, the issue
of timely diagnosis and early treatment of this disease is very
relevant. The article presents a clinical case of renal amyloidosis.
Keywords: amyloidosis; clinical case; kidneys
58 Íèðêè, ISSN 2307-1257 (print), ISSN 2307-1265 (online) Òîì 9, ¹ 3, 2020